The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia [PDF]
Asian Journal of Urology, 2018 Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including ...
Eric H. Kim +2 more
doaj +4 more sources
Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study. [PDF]
PLoS ONE, 2015 This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alpha-reductase inhibitor therapy for benign prostate hyperplasia (BPH) using the National Health Insurance Research Database (NHIRD) in Taiwan.In total, 1 ...
Teng-Fu Hsieh +8 more
doaj +2 more sources
The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study [PDF]
The World Journal of Men's HealthPurpose: To investigate the long-term effects of taking 5-alpha reductase inhibitors (5ARIs) on the development of bladder cancer (BC) and the implementation of radical cystectomy (RC), a standard procedure for advanced BC.
Jong Hyun Pyun +5 more
doaj +2 more sources
5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis [PDF]
International Brazilian Journal of Urology, 2018 Objective: To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). Material and Methods: We systematically searched Medline via PubMed, Embase and the Cochrane Library Central Register up to May 2017 ...
Jiamin Wang +5 more
doaj +2 more sources
Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors [PDF]
The World Journal of Men's Health, 2020 Cara A. Foldes +2 more
doaj +2 more sources
May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? [PDF]
Med Hypotheses, 2020 COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females.
Adamowicz J, Juszczak K, Drewa T.
europepmc +2 more sources
Post-finasteride syndrome, [PDF]
Anais Brasileiros de Dermatologia, 2020 Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects.
Ana Francisca Junqueira Ribeiro Pereira +1 more
doaj +1 more source
High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia [PDF]
Journal of Urology, 2020 Aria F. Olumi +2 more
exaly +2 more sources
Clinics, 2018 OBJECTIVES: To assess the associations between preoperative treatment with 5-alpha reductase inhibitors and the risks of blood transfusion during transurethral resection of the prostate and blood clot evacuation or emergency department visits for ...
Ti-Yuan Yang +6 more
doaj +1 more source
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia [PDF]
Investigative and Clinical Urology, 2020 Purpose: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH).
Jae Seung Chung +11 more
doaj +1 more source